Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Vet Pathol ; 53(3): 585-93, 2016 May.
Artículo en Inglés | MEDLINE | ID: mdl-26508695

RESUMEN

After the introduction of West Nile virus (WNV) into North America, bird mortalities associated with West Nile disease have dramatically increased in this continent and, to a lesser extent, in Europe. The different West Nile disease incidence in birds in these 2 continents demands an explanation, and experimental studies can provide important information. The authors inoculated thirteen 9-week-old red-legged partridges (Alectoris rufa) with 10(7)plaque-forming units of a WNV strain isolated in New York in 1999. The objective was to study the pathogenesis of the infection in a native Euro-Mediterranean bird species with a WNV strain known to be highly pathogenic for numerous native American bird species. Additionally, the authors evaluated the dynamics of inflammatory cell activation and recruitment into the brain. WNV was detected in tissues 3 days postinoculation (dpi), and the birds developed macroscopic and microscopic lesions. Two partridges succumbed to the disease. The most affected tissues were the heart, brain, and spinal cord. The main microscopic findings were the presence of mononuclear infiltrates in the heart and brain, gliosis, and degeneration and necrosis of cardiomyocytes and neurons. These lesions were aggravated in the birds that died or were euthanized 7 dpi or later. In the brain, there was an upregulation of microglial cells and astrocytes and an increase in the number of T cells, especially after 7 dpi. These results show that this WNV strain is of moderate virulence for the red-legged partridge and that WNV-infected red-legged partridges develop an immune cell response in the brain similar to that of mammals.


Asunto(s)
Enfermedades de las Aves/virología , Encefalitis Viral/veterinaria , Galliformes , Fiebre del Nilo Occidental/veterinaria , Virus del Nilo Occidental/patogenicidad , Animales , Enfermedades de las Aves/inmunología , Enfermedades de las Aves/patología , Encéfalo/patología , Encéfalo/virología , Encefalitis Viral/inmunología , Encefalitis Viral/patología , Encefalitis Viral/virología , Corazón/virología , Inmunohistoquímica , Miocardio/patología , New York , América del Norte , Médula Espinal/patología , Médula Espinal/virología , Virulencia , Fiebre del Nilo Occidental/inmunología , Fiebre del Nilo Occidental/patología , Fiebre del Nilo Occidental/virología , Virus del Nilo Occidental/inmunología
2.
Vet Pathol ; 51(6): 1113-6, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-24395913

RESUMEN

Using eye samples of nine 9-week-old experimentally West Nile virus (WNV)-infected red-legged partridges (Alectoris rufa), time course of lesions and WNV antigen appearance in ocular structures were examined. In addition, eye samples of 6 red-legged partridges and 3 common pheasants (Phasianus colchicus) naturally infected with Bagaza virus (BAGV) were used to study lesions and flavivirus antigen distribution in relation to apparent blindness in the former. The rapid onset of microscopic lesions and early presence of viral antigen in the eye of experimentally WNV-infected partridges, prior to the central nervous system involvement, suggested hematogenous spread of the virus into the eye. BAGV-infected partridges had a more pronunced inflammatory reaction and more widespread flavivirus antigen distribution in the retina compared with pheasants and experimentally fatally WNV-infected partridges. Our results suggest that flavivirus replication and development of lesions in ocular structures of gallinaceous game birds vary with the specific virus and host species involved.


Asunto(s)
Enfermedades de las Aves/patología , Infecciones Virales del Ojo/veterinaria , Infecciones por Flavivirus/veterinaria , Flavivirus/patogenicidad , Galliformes/virología , Animales , Antígenos Virales/análisis , Antígenos Virales/inmunología , Enfermedades de las Aves/virología , Ojo/inmunología , Ojo/patología , Ojo/virología , Infecciones Virales del Ojo/patología , Infecciones Virales del Ojo/virología , Flavivirus/inmunología , Infecciones por Flavivirus/patología , Infecciones por Flavivirus/virología , Interacciones Huésped-Patógeno , Especificidad de la Especie
3.
Vaccine ; 31(41): 4523-7, 2013 Sep 23.
Artículo en Inglés | MEDLINE | ID: mdl-23933372

RESUMEN

West Nile virus (WNV) is maintained in nature in an enzootic transmission cycle between birds and mosquitoes, although it occasionally infects other vertebrates, including humans, in which it may result fatal. To date, no licensed vaccines against WNV infection are available for birds, but its availability would certainly benefit certain populations, as birds grown for restocking, hunting activities, or alimentary purposes, and those confined to wildlife reservations and recreation installations. We have tested the protective capability of WNV envelope recombinant (rE) protein in red-legged partridges (Alectoris rufa). Birds (n=28) were intramuscularly immunized three times at 2-weeks interval with rE and a control group (n=29) was sham-immunized. Except for 5 sham-immunized birds that were not infected and housed as contact controls, partridges were subcutaneously challenged with WNV. Oropharyngeal and cloacal swabs and feather pulps were collected at several days after infection and blood samples were taken during vaccination and after infection. All rE-vaccinated partridges elicited anti-WNV antibodies before challenge and survived to the infection, while 33.3% of the sham-immunized birds succumbed, as did 25% of the contact animals. Most (84%) unvaccinated birds showed viremia 3 d.p.i., but virus was only detected in 14% of the rE vaccinated birds. WNV-RNA was detected in feathers and swabs from sham-immunized partridges from 3 to 7 d.p.i., mainly in birds that succumbed to the infection, but not in rE vaccinated birds. Thus, rE vaccination fully protected partridges against WND and reduced the risk of virus spread.


Asunto(s)
Enfermedades de las Aves/prevención & control , Proteínas del Envoltorio Viral/inmunología , Fiebre del Nilo Occidental/veterinaria , Vacunas contra el Virus del Nilo Occidental/inmunología , Virus del Nilo Occidental/inmunología , Animales , Anticuerpos Antivirales/sangre , Enfermedades de las Aves/inmunología , Sangre/virología , Cloaca/virología , Galliformes , Inyecciones Intramusculares , Orofaringe/virología , Proteínas Recombinantes/genética , Proteínas Recombinantes/inmunología , Análisis de Supervivencia , Vacunación/métodos , Vacunas Sintéticas/administración & dosificación , Vacunas Sintéticas/inmunología , Proteínas del Envoltorio Viral/genética , Fiebre del Nilo Occidental/inmunología , Fiebre del Nilo Occidental/prevención & control , Vacunas contra el Virus del Nilo Occidental/administración & dosificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA